Previous close | 0.0101 |
Open | 0.0100 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0093 - 0.0109 |
52-week range | 0.0090 - 0.0700 |
Volume | |
Avg. volume | 6,092,593 |
Market cap | 9.886M |
Beta (5Y monthly) | 1.67 |
PE ratio (TTM) | 1.07 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Natural Shrimp, Incorporated. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced that, as a result of significantly increased production at its Webster City facility, the Company is in the process of identifying, contacting and securing new commercial outlets for the sale of the Company's sushi grade shrimp.
Natural Shrimp, Inc. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced it has completed at the end of February 2024 a successful 6-month trial in Japan with the Company's patented Electrocoagulation (EC) and Hydrogas™ technologies (the "Equipment").
Natural Shrimp Incorporated (OTCQB: SHMP), a Biotechnology Aquaculture Company (the "Company") that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), is pleased to announce that the Company has filed an initial application to list its securities on the Chicago Board of Options Exchange (Cboe US) BZX exchange (the "Exchange"). In addition, the Company has extended its engagement with its investment banking partner to underwrite a